Clinical Trial Update: PK/PD Investigation of Modufolin (Arfolitixorin) in Plasma, Tumor and Adjacent Mucosa Adjacent Mucosa in Patients With Colon Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating PK/PD of Modufolin (Arfolitixorin) in plasma, tumor, and adjacent mucosa for colorectal cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colonic Neoplasms
• Colorectal Cancer

Drugs mentioned

• Modufolin (Arfolitixorin)

Snippet

Sponsor: Isofol Medical AB | Conditions: Colonic Neoplasms | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-07-17